Dr. Rodrigo C. Chan, MD

Dr. Chan practices at Banner Baywood Medical Center in Mesa, Arizona, part of Banner Health.

Dr. Chan's NPI, 1659349512, was assigned on March 8, 2006. Dr. Chan graduated from University of the Philippines College of Medicine in 1983. Dr. Chan holds Arizona license 29915.

Dr. Chan's primary practice is Banner Baywood Medical Center, at 6644 East Baywood Avenue, Mesa, AZ 85206 in Maricopa County. The practice phone is (480) 321-2000.

Dr. Chan's primary practice is Banner Baywood Medical Center in Mesa, Arizona, part of Banner Health. Dr. Chan is also affiliated with Banner Desert Medical Center. The medical group on file is Southwest Cardiovascular Associates. Dmand AI also links Dr. Chan to 2 more hospitals, 2 group practices and clinics, 1 breast imaging center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chan practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Chan's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Chan's licenses on file in 5 states: Arizona, California, Minnesota, Michigan and Maryland.

Dmand AI lists atrial fibrillation and flutter, cardiac arrhythmia, heart blockage, intermittent racing heartbeat (PSVT), pacemaker or defibrillator implantation, pacemaker replacement, sick sinus syndrome and ventricular tachycardia among the conditions Dr. Chan treats.

CMS data shows 17,931 Medicare services from Dr. Chan across 42 procedure codes in 2024, for 1,013 Medicare patients. Medicare paid $1,121,590 for them.

CMS counts 1,013 Medicare patients who saw Dr. Chan in 2024. The largest group is 75 to 84, with 409 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chan's median patient age at 73, with 50% women.

In 2024, Dr. Chan wrote 9,216 Medicare Part D claims for 1,108 patients. 80% of them were for generic drugs. CMS names the drug for 8,839 of them, across 92 drugs with 11 or more claims each, at $2,114,801 in total drug cost. In 2023, CMS named 8,698 claims across 83 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 19 out of 100 for Dr. Chan for performance year 2024, reported individually. CMS lists Dr. Chan as offering telehealth. CMS counts 43 procedures of pacemaker insertion or repair by Dr. Chan, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Chan, published from 2018 to 2020. 2018 was the busiest year, with 2. The most frequent topics are Catheter Ablation, Dogs and Echocardiography. Dr. Chan's most frequent co-authors are Phi Wiegn, MD, William T. Abraham, MD and David D. Gutterman, MD.

Dmand AI links Dr. Chan to 7 clinical trials. 1 is still active or recruiting. Conditions studied include Heart Failure and Heart Diseases. CVRx, Inc. sponsors the most, 3.

CMS Open Payments shows 1,326 general payments to Dr. Chan from 58 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 44% of the total. CVRx, Inc. paid the most, $37,213.

Dmand AI lists 3 awards for Dr. Chan, most recently CMS Stage 1 EHR in 2013.

Dr. Chan graduated from University of the Philippines College of Medicine in 1983. Dr. Chan is a member of ACC.

Dr. Chan is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.